A new study presented at the European Association for the Study of the Liver in Berlin this month has renewed hopes for a possible cure for the hepatitis C virus (HCV).

The study — conducted by mostly US researchers — showed two new drugs, in combination with standard-of-care hep C treatment, were able to deliver positive results for those suffering chronic hep C who had previously not responded to standard treatment.

In the study, four of 11 patients treated with the two drugs experienced a long-term positive response, without the need for a more toxic drug regime, www.hivandhepatitis.com reports.

The results mean hep C sufferers may avoid the side effects of drugs interferon and ribavirin.

Most side effects of the new direct-acting drugs were said to be moderate.

Researchers said the results show the two new drugs could change the course of hep C treatment in the future.

© Star Observer 2019 | For the latest in lesbian, gay, bisexual, transgender and intersex (LGBTI) news in Australia, be sure to visit starobserver.com.au daily. You can also read our latest magazines or Join us on our Facebook page and Twitter feed.